Susquehanna International Group
IGC icon

Susquehanna International Group’s IGC Pharma IGC Stock Holding History

Susquehanna International Group’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,100
Closed -$5.08K – 12921
2025
Q3 		$5.08K Buy
+12,100
New +$4.6K ﹤0.01% 12131
2024
Q1 		– Sell
-15,900
Closed -$4.45K – 12689
2023
Q4 		$4.45K Sell
15,900
-100
-0.6% -$31 ﹤0.01% 12133
2023
Q3 		$5.76K Sell
16,000
-2,500
-14% -$894 ﹤0.01% 11774
2023
Q2 		$5.74K Sell
18,500
-100
-0.5% -$32 ﹤0.01% 11814
2023
Q1 		$6.32K Sell
18,600
-6,400
-26% -$2.4K ﹤0.01% 12277
2022
Q4 		$8K Sell
25,000
-10,700
-30% -$4.36K ﹤0.01% 11971
2022
Q3 		$15K Sell
35,700
-20,100
-36% -$10.7K ﹤0.01% 12697
2022
Q2 		$30K Sell
55,800
-20,900
-27% -$13.2K ﹤0.01% 12220
2022
Q1 		$73K Buy
76,700
+55,300
+258% +$53.7K ﹤0.01% 12104
2021
Q4 		$21K Sell
21,400
-90,000
-81% -$121K ﹤0.01% 12817
2021
Q3 		$165K Sell
111,400
-84,300
-43% -$136K ﹤0.01% 11705
2021
Q2 		$321K Buy
195,700
+35,800
+22% +$54.6K ﹤0.01% 10629
2021
Q1 		$286K Buy
159,900
+92,200
+136% +$167K ﹤0.01% 10708
2020
Q4 		$106K Buy
67,700
+32,300
+91% +$47.7K ﹤0.01% 10467
2020
Q3 		$37K Buy
+35,400
New +$36K ﹤0.01% 10277
2019
Q2 		– Sell
-34,500
Closed -$72K – 10502
2019
Q1 		$72K Buy
+34,500
New +$78.4K ﹤0.01% 8375

Other funds holding IGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
LC
Lawood & Co Williamsport, Pennsylvania $148M AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DP
Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return

Susquehanna International Group's IGC Position: Q1 2026 in Review

Susquehanna International Group reduced its IGC Pharma (IGC) stake by 21% in Q1 2026, selling an estimated $8.98K and leaving 122,595 shares worth $32.2K. The position accounts for ﹤0.01% of the portfolio, ranked #12748.

Susquehanna International Group first reported a position in IGC in Q1 2016 and has held it in 26 quarters since. The position peaked at $878K in Q1 2021. 35 funds tracked by Wall St. Rank hold IGC as of Q1 2026.

  • Susquehanna International Group held 122,595 shares of IGC Pharma worth $32.2K as of Q1 2026.
  • Susquehanna International Group sold 32,364 IGC Pharma shares in Q1 2026, an estimated $8.98K.
  • IGC Pharma made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12748 holding.
  • Susquehanna International Group first reported a position in IGC Pharma in Q1 2016 and has held it in 26 quarters since.
  • Susquehanna International Group's IGC Pharma position peaked at $878K in Q1 2021.
  • 35 funds tracked by Wall St. Rank held IGC Pharma as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.